| | | | | | | |
 | IQVIA HOLDINGS INC. | -0.89% | 2.58% | -23.78% | -12.98% | 33.82% | 41 072 |
 | LONZA GROUP AG | 2.00% | 4.30% | -31.83% | -21.00% | 55.40% | 39 547 |
| SEAGEN INC. | 1.79% | 1.69% | 16.50% | 13.80% | 163.51% | 32 570 |
 | CELLTRION, INC. | 0.28% | 1.99% | -9.60% | -31.75% | -5.99% | 19 048 |
| ALNYLAM PHARMACEUTICALS, INC. | 1.65% | -0.31% | -12.58% | -12.67% | 105.87% | 17 621 |
| ICON PUBLIC LIMITED COMPANY | -1.84% | -0.36% | -31.32% | -1.45% | 38.19% | 17 616 |
 | PHARMARON BEIJING CO., LTD. | 0.55% | 0.87% | 1.66% | -36.08% | 304.42% | 16 084 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | 0.74% | 6.94% | -9.78% | -43.62% | 123.88% | 14 097 |
| BIO-TECHNE CORPORATION | 1.89% | 0.39% | -31.73% | -22.19% | 68.78% | 13 600 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2.27% | -3.00% | -41.92% | -41.28% | 52.31% | 10 871 |
| QIAGEN N.V. | 1.38% | 5.29% | -13.91% | -2.41% | 17.60% | 10 736 |
| UNITED THERAPEUTICS CORPORATION | 1.00% | -2.17% | 10.14% | 28.88% | 190.07% | 10 674 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | -0.27% | 1.05% | 5.44% | 45.75% | 235.90% | 10 352 |
 | GENSCRIPT BIOTECH CORPORATION | 1.61% | 4.79% | -17.54% | -16.08% | 45.01% | 7 656 |
| SYNEOS HEALTH, INC. | -0.15% | 2.53% | -30.30% | -19.68% | 39.08% | 7 353 |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
